Asthma drug, Xolair, introduced as prefilled syringe

The asthma treatment which has not been able to pass the wall of the health insurance since its approval in 2007, Xolair(generic name: omalizumab), was introduced as a prefilled syringe type.

According to the Ministry of Food and Drug Safety, Novartis Korea acquired domestic commercialization approval of Xolair Prefilled Syringe 150on the 27^th.

Xolair is a drug representing efficacy on severe...